Pharmacogenomics Hub in a strengthened IMGGE

Informations projet

PharmGenHUB

N° de convention de subvention: 101059870

DOI

10.3030/101059870

Projet clôturé

Date de signature de la CE 6 Avril 2022

Date de début 1 Juillet 2022

Date de fin 30 Juin 2025

Financé au titre de

• Widening participation and spreading excellence

Coût total

€ 1 339 250,00

Contribution de l’UE

€ 1 339 250,00

Coordonné par

INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO
Serbia

CORDIS fournit des liens vers les livrables publics et les publications des projets HORIZON.

Les liens vers les livrables et les publications des projets du 7e PC, ainsi que les liens vers certains types de résultats spécifiques tels que les jeux de données et les logiciels, sont récupérés dynamiquement sur OpenAIRE .

Livrables

Documents, reports (8)

First report on the bioinformatics trainings at UPAT
Strengthened transferable and soft skills of the IMGGE staff
Setting up a RMU at IMGGE

RMU will be set up at the kickoff meeting M1 by appointing staff from IMGGE

First report on the human iPSC-based model system trainings at UNITS

First report on the human iPSCbased model system trainings at UNITS

Plan for dissemination, exploitation and communication (kick-off meeting)

Initial plan for dissemination exploitation and communication

Kick-off meeting report and naming the Project Management Board and Advisory Board

Kickoff meeting report and naming the Project Management Board and Advisory Board

First report on the advanced statistics trainings at UL
Data management plan (Kick-off meeting)

Data management plan initial following Kickoff meeting

Websites, patent fillings, videos etc. (2)

Interactive web site

Interactive web site will be created where information regarding the aims of the Project progress in achieving goals and relevant supporting will be available at all times and updated monthly from month 6 The web site will be also accessible through IMGGE web site wwwimggebgacrs and will be bilingual Serbian and English languages

Leaflets containing information on significance and clinical use of pharmacogenomics markers.

Leaflets containing information on significance and clinical use of pharmacogenomics markers Three leaflets are planned

Publications

Peer reviewed articles (3)

Comprehensive pharmacogenomics profiling of the Serbian population

Auteurs: Marina Jelovac, Djordje Pavlovic, Biljana Stankovic, Nikola Kotur, Bojan Ristivojevic, Sonja Pavlovic, Branka Zukic
Publié dans: Frontiers in Pharmacology, Numéro 16, 2025, ISSN 1663-9812
Éditeur: Frontiers Media SA
DOI: 10.3389/FPHAR.2025.1553536

The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity

Auteurs: Debora Curci, Biljana Stankovic, Nikola Kotur, Letizia Pugnetti, Vladimir Gasic, Maurizio Romano, Branka Zukic, Giuliana Decorti, Gabriele Stocco, Marianna Lucafò, Sonja Pavlovic
Publié dans: Frontiers in Pharmacology, Numéro 15, 2024, ISSN 1663-9812
Éditeur: Frontiers Media SA
DOI: 10.3389/FPHAR.2024.1448136

The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress

Auteurs: van Schaik RH, Manolopoulos VG, Daly AK, Niemi M, Zukic B, Patrinos GP, Primorac D, Swen JJ, Ingelman-Sundberg M, Morris T, Molden E, Müller D, Pavlovic S, Russmann S, Ansari M, Henricks LM, den Broek WV, Florindi F, Bozina N, Akin D, Christrup L, Llerena
Publié dans: Pharmacogenomics, Numéro 24(5), 2023, ISSN 1462-2416
Éditeur: Ashley Publications Ltd.
DOI: 10.2217/PGS-2023-0013